Antone, Jenilyn C.
HRN: 22-57-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/07/2023
02/13/2023
IV
500mg
Q8h
AGE With Severe DHN
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes